Literature DB >> 9084993

Survival after AIDS diagnosis in Tuscany (Italy), 1985-1992.

A Barchielli1, S Acciai, V Lazzeri, E Buiatti.   

Abstract

The study evaluated the overall survival after AIDS diagnosis of 1,014 patients reported to the Italian AIDS Registry as resident in Tuscany, stratified by age, gender, year of diagnosis, HIV transmission category, initial AIDS-defining disease and CD4+ cells count. The study was a population-based survival analysis, carried out through Kaplan-Meier method (mean survival times-MST-, 1, 2 and 3-year observed survival) and Cox models (crude and adjusted relative risk-RR). The MST was 12.4 months for all cases, increasing from 4-7 months in 1985-1987 to 14 months in 1991-1992. The observed survival was 51.4% at the first year of follow-up, 28.4% at the second year and 14.5% at the third year. The multivariate analysis showed an independent prognostic effect of age, year of diagnosis, initial AIDS-defining disease and CD4+ cells count. The prognosis was worse in cases aged over 44 (reference: 25-29), diagnosed before 1988 (reference: 1991) and with wasting syndrome, toxoplasmosis, HIV encephalopathy or multiple diseases (reference: PCP alone); and better in cases with more than 100 CD4+ cells/mm3 (reference: < or = 50 cells/mm3). The differences in gender and among HIV transmission categories disappeared after age-adjustment. The study confirmed, in an European population-based series, the poor long-term AIDS prognosis and, once AIDS has became clinically manifest, the prognostic value of some clinical and demographic variables.

Entities:  

Mesh:

Year:  1997        PMID: 9084993     DOI: 10.1023/a:1007323722805

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  24 in total

1.  Impact of treatment and prophylaxis on presentation and survival of patients with AIDS in Milan.

Authors:  A Monforte; F Mainini; M Musicco; T Formenti; M Mena; T Bini; M Moroni
Journal:  Lancet       Date:  1995-12-02       Impact factor: 79.321

2.  Primary prophylaxis against opportunistic infections in patients with AIDS.

Authors:  N Clumeck
Journal:  N Engl J Med       Date:  1995-03-16       Impact factor: 91.245

3.  Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.

Authors:  J D Lundgren; A N Phillips; C Pedersen; N Clumeck; J M Gatell; A M Johnson; B Ledergerber; S Vella; J O Nielsen
Journal:  JAMA       Date:  1994-04-13       Impact factor: 56.272

4.  Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays.

Authors:  S E Whitmore-Overton; H E Tillett; B G Evans; G M Allardice
Journal:  AIDS       Date:  1993-03       Impact factor: 4.177

5.  Trends in mortality among AIDS patients in Amsterdam, 1982-1988.

Authors:  P J Bindels; R M Poos; J T Jong; J W Mulder; H J Jager; R A Coutinho
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

6.  Survival with AIDS in Massachusetts, 1979 to 1989.

Authors:  G R Seage; S Oddleifson; E Carr; B Shea; L Makarewicz-Robert; M van Beuzekom; A De Maria
Journal:  Am J Public Health       Date:  1993-01       Impact factor: 9.308

7.  Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.

Authors:  L P Jacobson; A J Kirby; S Polk; J P Phair; D R Besley; A J Saah; L A Kingsley; L K Schrager
Journal:  Am J Epidemiol       Date:  1993-12-01       Impact factor: 4.897

8.  Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group.

Authors:  J D Lundgren; C Pedersen; N Clumeck; J M Gatell; A M Johnson; B Ledergerber; S Vella; A Phillips; J O Nielsen
Journal:  BMJ       Date:  1994-04-23

9.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  Survival trends of people with AIDS in Washington State.

Authors:  W E Lafferty; D Glidden; S G Hopkins
Journal:  Am J Public Health       Date:  1991-02       Impact factor: 9.308

View more
  1 in total

1.  How complete is AIDS surveillance in Europe? An eagle eye comparison with mortality data.

Authors:  V Ajdacic-Gross; U Zellweger; J Wang; Y Fleerackers; B Somaini
Journal:  J Epidemiol Community Health       Date:  2001-01       Impact factor: 3.710

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.